BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38381845)

  • 1. Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease.
    Czech M; Schneider S; Peltokangas N; El Khawanky N; Ghimire S; Andrieux G; Hülsdünker J; Krausz M; Proietti M; Braun LM; Rückert T; Langenbach M; Schmidt D; Martin I; Wenger V; de Vega E; Haring E; Pourjam M; Pfeifer D; Schmitt-Graeff A; Grimbacher B; Aumann K; Kircher B; Tilg H; Raffatellu M; Thiele Orberg E; Häcker G; Duyster J; Köhler N; Holler E; Nachbaur D; Boerries M; Gerner RR; Grün D; Zeiser R
    Sci Transl Med; 2024 Feb; 16(735):eadi1501. PubMed ID: 38381845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF-Induced Suppressor IL-10+ Neutrophils Promote Regulatory T Cells That Inhibit Graft-Versus-Host Disease in a Long-Lasting and Specific Way.
    Perobelli SM; Mercadante AC; Galvani RG; Gonçalves-Silva T; Alves AP; Pereira-Neves A; Benchimol M; Nóbrega A; Bonomo A
    J Immunol; 2016 Nov; 197(9):3725-3734. PubMed ID: 27707998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Han L; Zhang H; Chen S; Zhou L; Li Y; Zhao K; Huang F; Fan Z; Xuan L; Zhang X; Dai M; Lin Q; Jiang Z; Peng J; Jin H; Liu Q
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1944-1955. PubMed ID: 31299215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages.
    Toyonaga T; Matsuura M; Mori K; Honzawa Y; Minami N; Yamada S; Kobayashi T; Hibi T; Nakase H
    Sci Rep; 2016 Oct; 6():35014. PubMed ID: 27734904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
    Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
    Front Immunol; 2018; 9():2724. PubMed ID: 30534126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect.
    Gao J; Xu Y; Ma S; Liang Y; Liu C; Shen J; Sun Z; Niu M; Xu K; Pan B
    Transplant Cell Ther; 2022 Mar; 28(3):134.e1-134.e10. PubMed ID: 34896653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
    Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin 2 Protects Against
    Wang Q; Li S; Tang X; Liang L; Wang F; Du H
    Front Immunol; 2019; 10():2594. PubMed ID: 31781104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
    Shang T; Guo Y; Li XR; Zhou Z; Qi Y; Salahdiin K; Shen R; He S; Wang M; Shi ZX; Zhao X; Yang J; Fan G; Wang Y; Gao X; Zhu Y; Feng Y
    Biomed Pharmacother; 2022 Apr; 148():112675. PubMed ID: 35183993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lnc-AC145676.2.1-6-3 plays an important role in intestinal acute graft-versus-host disease through the regulation of interleukin-1β.
    Sun X; Xia M; Liu J; Cui J; Zhang Y; Sun R; Cui X
    Int J Lab Hematol; 2022 Aug; 44(4):759-768. PubMed ID: 35441492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
    Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.
    Su Y; Sun X; Liu X; Qu Q; Yang L; Chen Q; Liu F; Li Y; Wang Q; Huang B; Huang XJ; Zhang XH
    J Hematol Oncol; 2022 Jul; 15(1):99. PubMed ID: 35864538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Study of Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
    Wang Z; Tao F; Tang W; Nie YM; Yang L; Chen Z; Teng JX; Lu WJ; Qi SS; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):600-606. PubMed ID: 35396003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
    Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
    J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model.
    Cheng L; Xing H; Mao X; Li L; Li X; Li Q
    Scand J Immunol; 2015 Jan; 81(1):31-8. PubMed ID: 25359467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
    Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
    Front Immunol; 2021; 12():647894. PubMed ID: 34262560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
    Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.